Cerebrospinal Fluid Management Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI2811
Cerebrospinal Fluid Management (CSF) Market size is projected to experience significant growth from 2018 to 2024.
Rise in prevalence hydrocephalus in worldwide population should stimulate cerebrospinal fluid (CSF) management market growth over the forecast timeframe. According to Hydrocephalus Association, one in 1,000 new born and 1 in 100 elder people are diagnosed with hydrocephalus. In addition, factors such as tumors, infections and hemorrhage increase the risk of disease in pediatric population. Lack of preventive measures for this disease will further lead to increase in incidence rate. Availability of limited number of alternatives to cure hydrocephalus will thereby augment CSF management market growth in forthcoming period.
Increasing geriatric population will impel the demand for cerebrospinal fluid management devices in upcoming period. According to United Nations statistics, world geriatric population is estimated to double by 2050, reaching to about 2.1 billion. Elderly people are vulnerable to suffer from normal pressure hydrocephalus (NPH). Approximately 10-15% older population affected with dementia are expected to be suffering from treatable NPH. Thus, increasing number of elderly population, rise in number of dementia cases and other associated neurological disorders will positively impact market growth over the projected timeframe.
High cost of CSF management devices can restrain market growth. Although, availability of reimbursement policies can boost rise in market share in recent years. There is presence of reimbursements for various shunts in hospitals, outpatient departments as well as ambulatory surgical centers in some developed countries. This will favor rise in adoption of CSF management devices in developed nations, thereby fostering industry growth during the forecast timeframe.
However, complications associated with CSF management devices and large number of undiagnosed hydrocephalus cases will hinder market growth. Moreover, stringent regulatory scenario may impair business growth over the coming years.
Shunts segment will witness lucrative growth due to less number of alternative treatment for neurological disorders. Shunts offer benefits such as adjustability by magnetic devices as well as faster treatment rate. Moreover, replacement of shunts at regular time intervals will significantly drive segment growth in recent years.
Pediatric segment will witness remarkable growth owing to widespread occurrence of neurological disorders in new born population. The percentage of risk factors in infants is also high that leads to greater prevalence of hydrocephalus in children. Furthermore, availability of healthcare facilities for treating pediatric hydrocephalus will augment segmental growth in forthcoming years.
U.S. cerebrospinal fluid management market will show a considerable growth due to rising number patient pool suffering with hydrocephalus. According to Hydrocephalus Association, approximately one million of U.S. population is affected with the disease. Additionally, 700,000 elder Americans are living with NPH. Such high prevalence coupled with faster adoption of technology and favorable reimbursement scenario in the country should support regional growth in forthcoming period.
Prominent companies of global cerebrospinal fluid management market include B. Braun Melsungen, Deltasurgical, Dispomedica, G.Surgiwear, Integra Lifesciences, Medtronic, Moller Medical, Natus Medical, Sophysa, Spiegelberg and Wellong Instruments. These companies adopt strategic initiatives such as innovative product launch, partnership and geographical expansion for improving their market share. For instance, in February 2017, Integra Lifesciences announced about its decision to acquire Codman Neurosurgery Business that will fortify company’s product portfolio in neurology segment, thus increasing its customer base.
Cerebrospinal fluid management market by product, 2013-2024 (USD Million)
- By type
- By valve type
- External drainage systems
- External Ventricular Drainage (EVD) Systems
- Lumbar Drainage (LD) Systems
Cerebrospinal fluid management market by age-group, 2013-2024 (USD Million)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- South Korea
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- B. Braun Melsungen
- Integra Lifesciences
- Moller Medical
- Natus Medical
- Wellong Instruments
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.